Cognitive Impairment and Cardiovascular Risk in Older (DECRIVAM)

This study has been completed.
Sponsor:
Collaborator:
Grupo de Investigación de Atención Primaria de Castilla y León
Information provided by (Responsible Party):
Luis Garcia Ortiz, Fundacion para la Investigacion y Formacion en Ciencias de la Salud
ClinicalTrials.gov Identifier:
NCT01327196
First received: March 30, 2011
Last updated: September 4, 2014
Last verified: September 2014
  Purpose

The objective of this project is to study cognitive yields in people of the town of Salamanca over 65, with particular emphasis on the acquisition of the initial symptoms of cognitive impairment in order to detect mild cognitive impairment and study the relationship between the clinical situation and cardiovascular risk factors. It will depart from a reference population of 420 people older than 65 years living in the municipality of Salamanca which took part in a survey prior to partner health needs of the elderly of 65 years in the municipality of Salamanca. This was a stratified sampling as stratum considering the area of health. The results of this study are expected to evidence the extent of the problem of cognitive decline in the population over 65 years. It is also expected to determine the relationship between the co-morbidity in this problem and specific factors of cardiovascular risk in this group of population.


Condition
Cognitive Impairment
Cardiovascular Risk Factor

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: Detection of Mild Cognitive Impairment in People Older Than 65 Years of Age and Its Relationship to Cardiovascular Risk Factors (DECRIVAM)

Resource links provided by NLM:


Further study details as provided by Fundacion para la Investigacion y Formacion en Ciencias de la Salud:

Primary Outcome Measures:
  • Prevalence of risk factors cardiovascular [ Time Frame: Prevalence of risk factors cardiovascular ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • neuropsychological assessment [ Time Frame: neuropsychological assessment ] [ Designated as safety issue: No ]

Other Outcome Measures:
  • neuropsychological assessment [ Time Frame: neuropsychological assessment ] [ Designated as safety issue: No ]

Enrollment: 327
Study Start Date: June 2010
Study Completion Date: December 2012
Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Detailed Description:

A random sample population, the information obtained has a validity superior to other studies in which the sample has not followed very strict criteria of selection.

Protocol for measurement:

  • variable demographic partner
  • vascular risk factors
  • co-morbidity
  • functional level for the activities of daily life
  • cognitive performance in attention, memory, language, praxias, gnosias (abbreviated neuropsychological battery)

Through a battery short neuropsychological specially adapted for the study of older people will carry out a study of the cognitive performance in people older than 65 years of age and will try to establish how much influence the controlled variables of cardiovascular risk.

  Eligibility

Ages Eligible for Study:   65 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

It will depart from a reference population of 420 people older than 65 years living in the municipality of Salamanca

Criteria

Inclusion Criteria:

  • lives in the municipality of Salamanca
  • over 65 years of age
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01327196

Locations
Spain
Fundacion INFOSALUD
Salamanca, Spain, 37007
Sponsors and Collaborators
Fundacion para la Investigacion y Formacion en Ciencias de la Salud
Grupo de Investigación de Atención Primaria de Castilla y León
Investigators
Principal Investigator: MºVictoria Perea-Bartolome, MD Fundacion INFOSALUD
Study Director: Emiliano Rodriguez-Sanchez, MD Fundacion INFOSALUD
  More Information

Additional Information:
No publications provided by Fundacion para la Investigacion y Formacion en Ciencias de la Salud

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Luis Garcia Ortiz, Fundacion para la Investigacion y Formacion en Ciencias de la Salud
ClinicalTrials.gov Identifier: NCT01327196     History of Changes
Other Study ID Numbers: BIO39/SA04/10
Study First Received: March 30, 2011
Last Updated: September 4, 2014
Health Authority: SPAIN: COMITE ETICO DE ENSAYOS CLINICOS. HOSPITAL CLINICO DE SALAMANCA.

Keywords provided by Fundacion para la Investigacion y Formacion en Ciencias de la Salud:
dementia
cardiovascular risk
elderly
aging
older 65-100 years

Additional relevant MeSH terms:
Cognition Disorders
Mild Cognitive Impairment
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders

ClinicalTrials.gov processed this record on October 23, 2014